Doc328: Do you believe that the following is in general true or false???
Alzheimer's disease is easier to treat at the earliest stage possible.
The above is especially true if you are targeting upstream MOA with precision medicine.
See the image below to understand why this is true.
The Anavex Blarcamesine Phase 2b/3 trial is for early stage Alzheimer's disease with baseline MMSE scores of 20 to 28 inclusive Prevention of Alzheimer's disease via Blarcamesine or Anavex 3-71 would be the earliest stage possible.
AI
